New PET scans to reveal if sotatercept repairs damaged arteries in PAH
NCT ID NCT07357974
First seen Feb 01, 2026 · Last updated May 10, 2026 · Updated 19 times
Summary
This pilot study will test whether the drug sotatercept can reduce scarring and remodeling of blood vessels in the lungs of 15 people with pulmonary arterial hypertension (PAH). Researchers will use special PET/CT scans to see changes in the arteries and right side of the heart over 24 weeks. The goal is to learn if this imaging method can detect early improvements from the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION PAH are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Brest
Brest, Finistere, 29200, France
Contact
Conditions
Explore the condition pages connected to this study.